大学职业资格刷题搜题APP
创建自己的小题库
搜索
【单选题】
下列与PUBMED数据库的主题词检索无关的选项是（ ）。
A.
MeSH Subheadings [SH]
B.
Subset [SB]
C.
MeSH Terms [MH]
D.
MeSH Major Topic [MAJR]
相关题库：文献检索-2019秋冬
手机使用
分享
复制链接
新浪微博
分享QQ
微信扫一扫
反馈
收藏
举报
参考答案：
举一反三
【多选题】利用 PubMed 主题词检索出, 2012-2017 年有关多发性硬化症( Multiple Sclerosis )药物治疗的语种为 Chinese 的综述类文献若干,包括下列哪些文献?
A.
Research progress of the selective sphingosine-1-phosphate receptor 1 agonists
B.
Systematic review and meta-analysis of randomized controlled trials of Chinese herbal medicine in treatment of multiple sclerosis
C.
Equivalence of glatiramer acetate products: challenges in assessing pharmaceutical equivalence and critical clinical performance attributes
D.
Ocrelizumab: A New B-cell Therapy for Relapsing Remitting and Primary Progressive Multiple Sclerosis. Ann Pharmacother
E.
Multiple sclerosis, a treatable disease
相关题目：
【多选题】利用 PubMed 主题词检索出, 2012-2017 年有关多发性硬化症( Multiple Sclerosis )药物治疗的语种为 Chinese 的综述类文献若干,包括下列哪些文献?
A.
Research progress of the selective sphingosine-1-phosphate receptor 1 agonists
B.
Systematic review and meta-analysis of randomized controlled trials of Chinese herbal medicine in treatment of multiple sclerosis
C.
Equivalence of glatiramer acetate products: challenges in assessing pharmaceutical equivalence and critical clinical performance attributes
D.
Ocrelizumab: A New B-cell Therapy for Relapsing Remitting and Primary Progressive Multiple Sclerosis. Ann Pharmacother
E.
Multiple sclerosis, a treatable disease
参考解析：
题目纠错 0
发布
